Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kazuo Kitamura

Showing results (271-280 of 283) with videos related to

Pageof 29
Sort By:
Hypertension (Dallas, Tex. : 1979)|December 13, 2012
Hemodynamic and hormonal changes to dual renin-angiotensin system inhibition in experimental hypertensionNorihito Moniwa, Jasmina Varagic, Sarfaraz Ahmad, et al.
Frontiers in Endocrinology|June 3, 2024
Acyl modifications in bovine, porcine, and equine ghrelinsTakanori Ida, Hatsumi Tominaga, Eri Iwamoto, et al.
Eclinicalmedicine|December 2, 2024
Efficacy and safety of adrenomedullin for acute ischemic stroke (AMFIS): a phase 2, randomized, double-blinded, placebo-controlled, clinical trialTakeshi Yoshimoto, Satoshi Saito, Katsuhiro Omae, et al.
Diabetes/Metabolism Research and Reviews|July 18, 2013
Efficacy of alogliptin, a dipeptidyl peptidase-4 inhibitor, on glucose parameters, the activity of the advanced glycation end product (AGE) - receptor for AGE (RAGE) axis and albuminuria in Japanese type 2 diabetesKoji Sakata, Manabu Hayakawa, Yuichiro Yano, et al.
Cerebral Circulation - Cognition and Behavior|February 20, 2024
A multicenter, single-arm, phase II clinical trial of adrenomedullin in patients with cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathyKazuo Washida, Satoshi Saito, Tomotaka Tanaka, et al.
Journal of Gastroenterology and Hepatology|July 15, 2022
Adrenomedullin for biologic-resistant Crohn's disease: A randomized, double-blind, placebo-controlled phase 2a clinical trialToshihiro Kita, Shinya Ashizuka, Teruyuki Takeda, et al.
Journal of Gastroenterology|November 3, 2020
Adrenomedullin for steroid-resistant ulcerative colitis: a randomized, double-blind, placebo-controlled phase-2a clinical trialToshihiro Kita, Sinya Ashizuka, Naoki Ohmiya, et al.
Nature Methods|March 13, 2026
Isotonic and minimally invasive optical clearing media for live cell imaging ex vivo and in vivoShigenori Inagaki, Nao Nakagawa-Tamagawa, Nathan Zechen Huynh, et al.
Science Advances|July 11, 2017
Serotonin rebalances cortical tuning and behavior linked to autism symptoms in 15q11-13 CNV miceNobuhiro Nakai, Masatoshi Nagano, Fumihito Saitow, et al.
Viruses|July 30, 2025
Adrenomedullin Therapy for Moderate-to-Severe COVID-19 Pneumonia: Double-Blind Placebo-Controlled Phase 2a TrialToshihiro Kita, Norio Ohmagari, Sho Saito, et al.
Pageof 29

Showing results (271-280 of 283) with videos related to

Sort By:
Pageof 29
Hypertension (Dallas, Tex. : 1979)|December 13, 2012
Hemodynamic and hormonal changes to dual renin-angiotensin system inhibition in experimental hypertensionNorihito Moniwa, Jasmina Varagic, Sarfaraz Ahmad, et al.
Frontiers in Endocrinology|June 3, 2024
Acyl modifications in bovine, porcine, and equine ghrelinsTakanori Ida, Hatsumi Tominaga, Eri Iwamoto, et al.
Eclinicalmedicine|December 2, 2024
Efficacy and safety of adrenomedullin for acute ischemic stroke (AMFIS): a phase 2, randomized, double-blinded, placebo-controlled, clinical trialTakeshi Yoshimoto, Satoshi Saito, Katsuhiro Omae, et al.
Diabetes/Metabolism Research and Reviews|July 18, 2013
Efficacy of alogliptin, a dipeptidyl peptidase-4 inhibitor, on glucose parameters, the activity of the advanced glycation end product (AGE) - receptor for AGE (RAGE) axis and albuminuria in Japanese type 2 diabetesKoji Sakata, Manabu Hayakawa, Yuichiro Yano, et al.
Cerebral Circulation - Cognition and Behavior|February 20, 2024
A multicenter, single-arm, phase II clinical trial of adrenomedullin in patients with cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathyKazuo Washida, Satoshi Saito, Tomotaka Tanaka, et al.
Journal of Gastroenterology and Hepatology|July 15, 2022
Adrenomedullin for biologic-resistant Crohn's disease: A randomized, double-blind, placebo-controlled phase 2a clinical trialToshihiro Kita, Shinya Ashizuka, Teruyuki Takeda, et al.
Journal of Gastroenterology|November 3, 2020
Adrenomedullin for steroid-resistant ulcerative colitis: a randomized, double-blind, placebo-controlled phase-2a clinical trialToshihiro Kita, Sinya Ashizuka, Naoki Ohmiya, et al.
Nature Methods|March 13, 2026
Isotonic and minimally invasive optical clearing media for live cell imaging ex vivo and in vivoShigenori Inagaki, Nao Nakagawa-Tamagawa, Nathan Zechen Huynh, et al.
Science Advances|July 11, 2017
Serotonin rebalances cortical tuning and behavior linked to autism symptoms in 15q11-13 CNV miceNobuhiro Nakai, Masatoshi Nagano, Fumihito Saitow, et al.
Viruses|July 30, 2025
Adrenomedullin Therapy for Moderate-to-Severe COVID-19 Pneumonia: Double-Blind Placebo-Controlled Phase 2a TrialToshihiro Kita, Norio Ohmagari, Sho Saito, et al.
Pageof 29